MIRM — MIRUM PHARMACEUTICALS INC

Ownership history in FORA Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which FORA Capital, LLC reported a position in MIRUM PHARMACEUTICALS INC (MIRM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q3)
Avg. % of fund
0.06%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 5,140 -5,086 -49.7% 0.07% $377K $73.31
2024 Q3 INITIATED 10,226 — — 0.05% $399K $39.00
% of Fund (quarterly)    MIRM price (monthly, adj. close)

Other funds also holding MIRM

As of 2025 Q4 — sorted by position size

Frazier Life Sciences Management, L.P. 3Y 14.42% BOONE CAPITAL MANAGEMENT LLC 3Y 10.44% Novo Holdings A/S 3Y 7Y 7.75% Patient Square Capital LP 3Y 5.05% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.82% First Turn Management, LLC 4.35% BVF INC/IL 3Y 7Y 3.98% Highlander Partners, L.P. 3Y 3.49% Rock Springs Capital Management LP 3Y 7Y 3.09% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 2.58%
← Back to FORA Capital, LLC Holdings